University of Rochester As Single-Cell Sequencing Methods Proliferate, Users Must Consider Application, ABRF Speakers Say Speakers at this year's ABRF meeting described how they used single-cell tools in combination with other single-cell approaches and other methods. Admera, University of Rochester Partner on PGx Pain Management Study The study will use Admera's PGxOne Plus test, which uses next-generation sequencing technology to interrogate genes in order to predict how patients will respond to drug therapy. NIH Names Semifinalists in $20M Antibiotic Resistance Dx Competition The semifinalists will receive $50,000 each to develop prototypes of their concepts for submission in the second phase of the challenge. URMC Inks Deal With Indivumed to Create Cancer Tissue Bank The medical center will provide samples from their patients and will have access to the company's clinical data and other biological samples. Scientists Evaluate Statistical Methods of Analyzing DNA Methylation on Microarrays Premium The optimal statistical method to find differences in methylation between case samples and control samples depends on the study's sample size. Jul 31, 2014 Researchers Describe 'Dunk and Swirl' Method to Allow Automated RT-PCR Analysis of Sputum Premium May 13, 2014 University of Rochester Reaps $4M Gift for Cancer Genomics Mar 13, 2014 Genomics in the Journals: 2014.03.13 May 28, 2013 IP Roundup: U of Rochester, Cargill, Branhaven, Nanohmics, Panagene Premium Sep 15, 2011 Diffinity Genomics Using Pair of NIH Grants to Develop New Nucleic Acid Purification Products Premium Oct 12, 2010 IP Roundup: Oct 12, 2010 Premium Jan 14, 2010 International Team Sequences Three Parasitoid Wasp Genomes Jan 14, 2010 Damon Runyon Funds High-Risk Cancer Studies Jan 7, 2010 NIH Awards Diffinity Genomics $717,229 Grant to Commercialize PCR Purification Product Premium Apr 8, 2009 Tech Transfer Tidbits: Apr 8, 2009 Premium Apr 7, 2009 With NY License in Hand, Quest to Add Array-Based Cyto Testing for Prenatal, Oncology Apps Premium Mar 23, 2009 BioRegion Real Estate: Mar 23, 2009 Premium Feb 5, 2009 NIH Funding for Proteomics Fall 3 Percent in FY 2008 as Number of Grants Slides 8 Percent Premium Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.